Big Stakes for Big Pharma in the Push Towards Full Enrollment in Part D
This article was originally published in RPM Report
Executive Summary
There are 4 million Medicare beneficiaries who have not yet joined the new drug benefit. The more who sign up in 2007, the better for Big Pharma.
You may also be interested in...
Medicare Rx in 2009: Re-Politicizing Drug Prices
Remember when the Democrats took over Congress and promised to do something about prescription drug prices under Part D? They didn't get very far, and they haven't been talking about it since. But when beneficiaries get ready to renew their Part D coverage in 2009-and see how much their costs are going up-there may be a lot more to talk about.
Medicare Rx in 2009: Re-Politicizing Drug Prices
Remember when the Democrats took over Congress and promised to do something about prescription drug prices under Part D? They didn't get very far, and they haven't been talking about it since. But when beneficiaries get ready to renew their Part D coverage in 2009-and see how much their costs are going up-there may be a lot more to talk about.
Making Part D Stick: Lessons From the First Year of Medicare Rx
Medicare beneficiaries stuck with their Part D plans heading into 2007. That gives insurers more leverage in price negotiations with big pharma. It also means Part D may be more likely to stick around despite critics in the Democratic Congress.